Discontinuing Psychiatric Medications: A Survey of Long-Term Users
Open accessThe DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index; 5 of the 32 sources its claims cite were checked for support.
Abstract
OBJECTIVE: Individuals undergoing long-term psychiatric treatment frequently choose to stop taking psychiatric medications. To enhance service user choice and prevent undesirable outcomes, this first U.S. survey of a large sample of longer-term users sought to increase knowledge about users' experience of medication discontinuation. METHODS: A sample of 250 U.S. adults with a diagnosis of serious mental illness and a recent goal to stop up to two prescribed psychiatric medications, which they had taken for at least nine months, completed a web-based survey about experiences, strategies, and supports during discontinuation. RESULTS: About half (54%) met their goal of completely discontinuing one or more medications; 46% reported another outcome (use was reduced, use increased, or use stayed the same). Concerns about medications' effects (for example, long-term effects and side effects) prompted the decision to discontinue for 74% of respondents. They used various strategies to cope with withdrawal symptoms, which 54% rated as severe. Self-education and contact with friends and with others who had discontinued or reduced medications were most frequently cited as helpful. Although more than half rated the initial medication decision with prescribers as largely collaborative, only 45% rated prescribers as helpful during discontinuation. Of respondents who completely discontinued, 82% were satisfied with their decision. CONCLUSIONS: Discontinuing psychiatric medication appears to be a complicated and difficult process, although most respondents reported satisfaction with their decision. Future research should guide health care systems and providers to better support patient choice and self-determination regarding the use and discontinuation of psychiatric medication.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
2 Valid · 3 Not valid · 15 Not checked · 51 Own results and interpretations
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“The lower rates of effects may be related to how long respondents took to discontinue.”
§ Discontinuing Psychiatric Medications: A Survey of Long-Term Users > DISCUSSION
What the sources say
- Could not verifycites [6] matched to “Examining the Relationship between Choice, Therapeutic Alliance and Outcomes in Mental Health Services” (2013) sourceExperimental — accuracy not yet measured
Our copy of Stanhope et al. (2013) is a cross-sectional secondary analysis of 396 service users who were actively enrolled and 'currently receiving psychiatric medication prescriptions from the community mental health clinic' (2.1 Participants and Procedures); its outcomes are recovery, quality of life and perceived outcomes (2.2 Measures; Table 2). No passage addresses discontinuing medication, withdrawal or discontinuation effects, or any comparison with a previous survey; the only 'length of time' variables are time in services and time with the psychiatrist (Table 1, Table 2), not time taken to discontinue. Searched for 'withdrawal effects', 'discontinue/discontinuation', 'previous survey' plus semantic neighbours — nothing on the claim's point, so the attribution can be neither confirmed nor contradicted. (LLM, conf=0.75)
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Moreover, withdrawal symptoms can occur after abrupt or gradual discontinuation of major psychiatric drugs (6,(11)(12)(13).”
§ Discontinuing Psychiatric Medications: A Survey of Long-Term Users > Abstract
What the sources say
- Could not verifycites [6] matched to “Examining the Relationship between Choice, Therapeutic Alliance and Outcomes in Mental Health Services” (2013) sourceExperimental — accuracy not yet measured
Our copy of Stanhope et al. (2013) is a study of choice, therapeutic alliance and recovery outcomes in severe mental illness; no passage addresses withdrawal symptoms or discontinuation of psychiatric drugs. Searches on 'withdrawal symptoms after discontinuation', 'abrupt stopping medication / tapering / adverse effects' and 'discontinuation / relapse / harms' returned only the paper's material on medication adherence and alliance (Introduction, pp. 1-2; Discussion, p. 4; Conclusions, p. 5) and its reference list. The claim's citation group (6,(11)(12)(13)) suggests the point may be carried by another work in that group, but nothing in our copy credits or reports withdrawal symptoms, so it can neither confirm nor contradict. (LLM, conf=0.72)
- Not checked yetcites [11] matched to “The effect of rate of antidepressant tapering on the incidence of discontinuation symptoms: a randomised study” (2008) source
- Supportedcites [12] matched to “Withdrawal Symptoms after Selective Serotonin Reuptake Inhibitor Discontinuation: A Systematic Review” (2015) source
The Introduction (p. 72) states that discontinuation symptoms, although mostly reported after abrupt suspension, 'were found to occur also after gradual tapering,' and the Abstract (p. 72) confirms symptoms occur 'also with gradual tapering.' The generalization to major psychiatric drugs is carried by the paper itself: the Abstract's conclusion urges clinicians to 'add SSRI to the list of drugs potentially inducing withdrawal symptoms upon discontinuation, together with benzodiazepines, barbiturates, and other psychotropic drugs,' and the Discussion (p. 78) treats withdrawal syndromes as established for benzodiazepines, antipsychotic drugs and tricyclic antidepressants. This is a systematic review reporting the findings rather than an original trial, which the citing sentence does not misrepresent. (LLM, conf=0.85)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“Individuals undergoing discontinuation have described experiencing the resurfacing of difficult emotions and withdrawal effects simultaneously (32).”
§ Discontinuing Psychiatric Medications: A Survey of Long-Term Users > DISCUSSION
What the sources say
- Could not verifycites [32] matched to “The 2009 schizophrenia PORT psychosocial treatment recommendations and summary statements” (2010) sourceExperimental — accuracy not yet measured
Our copy of the 2009 schizophrenia PORT psychosocial treatment recommendations contains no passage describing what individuals report when discontinuing treatment. Searches for 'discontinuation / withdrawal effects / resurfacing of difficult emotions' returned only the ACT evidence summary (Methods), which mentions persons 'at risk for discontinuation of treatment or for repeated crises' in the sense of needing coordinated services, and the adherence summary statement (Methods), which frames nonadherence to antipsychotic regimens as associated with relapse and hospitalization — neither addresses patient-reported withdrawal symptoms or emotional experiences. No contrary claim is stated, and no alternative source is credited in our copy for the point. (LLM, conf=0.72)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Of those who completely discontinued, most (N=105, 82%) were satisfied or very satisfied with their decision to discontinue.”
- Also stated in: § Abstract · plain
“Of respondents who completely discontinued, 82% were satisfied with their decision.”
§ Discontinuing Psychiatric Medications: A Survey of Long-Term Users > Discontinuation Status
plainn = 105- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Abstract · plain
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Respondents most commonly selected concerns about the medications' effects, such as longterm effects, side effects, and impact on reproductive health) (N=205, 85%);”
§ Discontinuing Psychiatric Medications: A Survey of Long-Term Users > Reasons for Discontinuation
plainn = 205- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
18 more claims
Create a free account to see all 71 claims and to verify the 27 references still open.
- Probably not a substantial claim. 22
- It may state two separate claims as one. 29
- The quote only partly states this claim. 1
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Research suggests those who are fully supported during drug withdrawal, either by peers (via groups such as those followed in this study), healthcare experts or support staff have a more successful outcome.8,13,48”
From The role of Facebook groups in the management and raising of awareness of antidepressant withdrawal: is social media filling the void left by health services? (2021) · cites this paper as [13]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“with a prevalence of 54% among adults with”
From Acute and Persistent Withdrawal Syndromes Following Discontinuation of Psychotropic Medications (2020) · cites this paper as [2]
Experimental — accuracy not yet measuredIn the citing paper
“Ostrow et al. reported that 54% of their participants rated withdrawal symptoms as severe.”
In the citing paper
“Moreover, the symptoms are physical as well as emotional and for some they persist for months or years,21–23 sometimes even after a very slow and careful taper.13,19”
In the citing paper
“Antidepressant users have reported severe and protracted withdrawal symptoms for decades via user surveys, help hotlines, or internet forums.38,62–67”
From Protracted withdrawal syndrome after stopping antidepressants: a descriptive quantitative analysis of consumer narratives from a large internet forum (2020) · cites this paper as [63]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Discontinuing Psychiatric Medications: A Survey of Long-Term Users > Abstract
“Concerns about medications' effects (for example, long-term effects and side effects) prompted the decision to 1232 ps.psychiatryonline.org discontinue for 74% of respondents.”
§ Discontinuing Psychiatric Medications: A Survey of Long-Term Users > Reasons for Discontinuation
“Respondents most commonly selected concerns about the medications' effects, such as longterm effects, side effects, and impact on reproductive health) (N=205, 85%)”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Discontinuing Psychiatric Medications: A Survey of Long-Term Users > DISCUSSION
“a larger proportion of respondents in this study took more than six months to discontinue (33% versus 7%)”
§ Discontinuing Psychiatric Medications: A Survey of Long-Term Users > Withdrawal Experiences
“About one-third (36%) chose to discontinue over a period of more than six months, another third (31%) did so in one to six months, and a third (33%) in less than one month”
Citations
Cites
Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia
Lieberman, J. A., Stroup, T. S., McEvoy, J. P., Swartz, M. S., Rosenheck, R. A., Perkins, D. O., Keefe, R. S. E., Davis, S. M., Davis, C. E., Lebowitz, B. D., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051688 · Cited by 5,892
Cochrane Database of Systematic Reviews
(2011) · Progress in Neurology and Psychiatry · doi:10.1002/pnp.208 · Cited by 4,667
Trivedi, M. H., Rush, A. J., Wisniewski, S. R., Nierenberg, A. A., Warden, D., Ritz, L., Norquist, G., Howland, R. H., Lebowitz, B., McGrath, P. J., et al. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.1.28 · Cited by 3,879
Good practice in the conduct and reporting of survey research
KELLEY, K. (2003) · International Journal for Quality in Health Care · doi:10.1093/intqhc/mzg031 · Cited by 2,157
Research summary on the therapeutic relationship and psychotherapy outcome.
Lambert, M. J., & Barley, D. E. (2001) · Psychotherapy: Theory, Research, Practice, Training · doi:10.1037/0033-3204.38.4.357 · Cited by 1,621
Ho, B.-C., Andreasen, N. C., Ziebell, S., Pierson, R., & Magnotta, V. (2011) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.199 · Cited by 971
The 2009 schizophrenia PORT psychosocial treatment recommendations and summary statements
Dixon, L. B., Dickerson, F., Bellack, A. S., Bennett, M., Dickinson, D., Goldberg, R. W., Lehman, A., Tenhula, W. N., Calmes, C., Pasillas, R. M., et al. (2010) · Schizophrenia Bulletin · doi:10.1093/schbul/sbp115 · Cited by 774
Perlis, R. H., Ostacher, M. J., Patel, J. K., Marangell, L. B., Zhang, H., Wisniewski, S. R., Ketter, T. A., Miklowitz, D. J., Otto, M. W., Gyulai, L., et al. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.2.217 · Cited by 689
SSRI Antidepressant Medications: Adverse Effects and Tolerability
Ferguson, J. M. (2001) · The Primary Care Companion For CNS Disorders · doi:10.4088/pcc.v03n0105 · Cited by 669
Insel, T. R. (2009) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2008.540 · Cited by 459 · cited 2×
“Previous studies of individuals who discontinue medication are generally limited to a single class of medication (3,5,6), with most participants using medication for less than six months (2).”
BackgroundFava, G. A., Gatti, A., Belaise, C., Guidi, J., & Offidani, E. (2015) · Psychotherapy and Psychosomatics · doi:10.1159/000370338 · Cited by 436 · cited 1×
“Initial studies have documented the withdrawal effects of various classes of drugs (5,6,13,34).”
BackgroundLong-Term Use of Antidepressants for Depressive Disorders and the Risk of Diabetes Mellitus
Andersohn, F., Schade, R., Suissa, S., & Garbe, E. (2009) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2008.08071065 · Cited by 314
Medication Adherence: A Review of the Literature and Implications for Clinical Practice
Julius, R. J., Novitsky, M. A., & Dubin, W. R. (2009) · Journal of Psychiatric Practice · doi:10.1097/01.pra.0000344917.43780.77 · Cited by 301
Antidepressant discontinuation reactions: Are preventable and simple to treat
Haddad, P., Lejoyeux, M., & Young, A. (1998) · BMJ · doi:10.1136/bmj.316.7138.1105 · Cited by 286
Adult Utilization of Psychiatric Drugs and Differences by Sex, Age, and Race
Moore, T. J., & Mattison, D. R. (2017) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2016.7507 · Cited by 207 · cited 2×
“use show that fewer people of color and fewer men are exposed to psychiatric drugs (1).”
BackgroundSweeney, A. (2009) · Cited by 173
Living Well With Chronic Illness: A Call for Public Health Action
(2015) · Military Medicine · doi:10.7205/milmed-d-15-00034 · Cited by 158
Peytchev, A. (2009) · Public Opinion Quarterly · doi:10.1093/poq/nfp014 · Cited by 131
Shared decision making for psychiatric medication management: beyond the micro‐social
Morant, N., Kaminskiy, E., & Ramon, S. (2016) · Health Expectations · doi:10.1111/hex.12392 · Cited by 129
Corrigan, P. W., Angell, B., Davidson, L., Marcus, S. C., Salzer, M. S., Kottsieper, P., Larson, J. E., Mahoney, C. A., O'Connell, M. J., & Stanhope, V. (2012) · Psychiatric Services · doi:10.1176/appi.ps.201100065 · Cited by 126
How Consumers/Survivors Are Evaluating the Quality of Psychiatric Care
Campbell, J. (1997) · Evaluation Review · doi:10.1177/0193841x9702100310 · Cited by 94
A Prescription for “Deprescribing” in Psychiatry
Gupta, S., & Cahill, J. D. (2016) · Psychiatric Services · doi:10.1176/appi.ps.201500359 · Cited by 84
Guo, J. Y., Huhtaniska, S., Miettunen, J., Jääskeläinen, E., Kiviniemi, V. J., Nikkinen, J., Moilanen, J. S., Haapea, M., Mäki, P. H., Jones, P. B., et al. (2015) · Schizophrenia Research · doi:10.1016/j.schres.2015.06.016 · Cited by 77
A systematic review of long-term studies of drug treated and non-drug treated depression
Hughes, S., & Cohen, D. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2009.01.027 · Cited by 71
Self-citationWhy is it so difficult to stop psychiatric drug treatment?
Moncrieff, J. (2006) · Medical Hypotheses · doi:10.1016/j.mehy.2006.03.009 · Cited by 59 · cited 1×
“Communication about discontinuation faces a challenge similar to that faced by research on discontinuation: it can be difficult to define and distinguish between withdrawal effects and psychiatric symptoms (11).”
BackgroundStanhope, V., Barrenger, S., Salzer, M., & Marcus, S. (2013) · Journal of Personalized Medicine · doi:10.3390/jpm3030191 · Cited by 48
Antidepressant Self-Discontinuation: Results From the Collaborative Psychiatric Epidemiology Surveys
Samples, H., & Mojtabai, R. (2015) · Psychiatric Services · doi:10.1176/appi.ps.201400021 · Cited by 45
Gibson, K., Cartwright, C., & Read, J. (2016) · BMC Psychiatry · doi:10.1186/s12888-016-0844-3 · Cited by 43
Liebrenz, M., Gehring, M.-T., Buadze, A., & Caflisch, C. (2015) · BMC Psychiatry · doi:10.1186/s12888-015-0493-y · Cited by 41
The psychiatric interview : a practical guide
Carlat, D. J. (1999) · Cited by 32
Consumer Outcomes After Implementing CommonGround as an Approach to Shared Decision Making
Salyers, M. P., Fukui, S., Bonfils, K. A., Firmin, R. L., Luther, L., Goscha, R., Rapp, C. A., & Holter, M. C. (2017) · Psychiatric Services · doi:10.1176/appi.ps.201500468 · Cited by 26 · cited 1×
“Increasingly, medication management is conceptualized not only as employing strategies to increase adherence but also as supporting patient goals for medication use (40).”
BackgroundExperiencing antipsychotic discontinuation: results from a survey of Australian consumers
Salomon, C., Hamilton, B., & Elsom, S. (2014) · Journal of Psychiatric and Mental Health Nursing · doi:10.1111/jpm.12178 · Cited by 25
Prescribing Mental Health Medication: The Practitioner's Guide
Doran, C. M. (2003) · Cited by 13
Tint, A., Haddad, P. M., & Anderson, I. M. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881107087488 · Cited by 13
Psychiatric Drugs: Key Issues and Service User Perspectives
Read, J. (2009) · Cited by 10
Read, J. (2009) · doi:10.1007/978-0-230-36441-7 · Cited by 9
Linton, O. (2008) · Academic Radiology · doi:10.1016/j.acra.2008.05.013 · Cited by 8
Prescribing Mental Health Medication: The Practitioner's Guide
Doran, C. (2013) · doi:10.4324/9780203111826 · Cited by 8
Research works printed but not linked: 3
- Stahl SM: Antipsychotics and Mood Stabilizers: Stahl's Essential Psychopharmacology. Cambridge, United Kingdom, Cambridge University Press, 2008
- Stahl SM: The Prescriber's Guide. Cambridge, United Kingdom, Cambridge University Press, 2011
- Improving the Quality of Health Care for Mental and Substance- Use Conditions: Quality Chasm Series. Washington, DC, National Academy of Sciences, 2006
Cited by
Acute and Persistent Withdrawal Syndromes Following Discontinuation of Psychotropic Medications
Cosci, F., & Chouinard, G. (2020) · Psychotherapy and Psychosomatics · doi:10.1159/000506868 · Cited by 265
Physical activity, exercise, and mental disorders: it is time to move on
Schuch, F. B., & Vancampfort, D. (2021) · Trends in Psychiatry and Psychotherapy · doi:10.47626/2237-6089-2021-0237 · Cited by 251
Vancampfort, D., Stubbs, B., Van Damme, T., Smith, L., Hallgren, M., Schuch, F., Deenik, J., Rosenbaum, S., Ashdown-Franks, G., Mugisha, J., et al. (2021) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2020.12.048 · Cited by 99
Hengartner, M. P., Schulthess, L., Sorensen, A., & Framer, A. (2020) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125320980573 · Cited by 74
Framer, A. (2021) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125321991274 · Cited by 73
Metadata
- Authors
- Ostrow, L., Jessell, L., Hurd, M., Darrow, S. M., & Cohen, D.
- Affiliations
- University of California, Los Angeles (US)
- Venue
- Psychiatric Services
- Published
- 2017-12-01
- Volume
- 68
- Issue
- 12
- Pages
- 1232-1238
- ISSN
- 0022-1597 (ISSN-L)
- 1075-2730
- 1557-9700
- OpenAlex
- W2736261103
- Cited by
- 62
- References
- 38
- Citations by year
- 2026: 4 · 2025: 8 · 2024: 7 · 2023: 6 · 2022: 4 · 2021: 12 · 2020: 6 · 2019: 9 · 2018: 5 · 2017: 1
- FWCI
- 8.22
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Psychiatric Services (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Foundation for Excellence in Mental Health Care
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
- Health Sciences › Health Professions › General Health Professions › Mental Health and Patient Involvement
- Social Sciences › Psychology › Clinical Psychology › Psychiatric care and mental health services
- Keywords
- severe mental illness, withdrawal symptoms, patient decision-making, patient satisfaction, self-determination, adverse drug reactions, self-education, peer support
- MeSH terms
- Adult, Mental Disorders, Female, Health Services Research, Humans, Male, Middle Aged, Patient Participation, Psychotropic Drugs, Substance Withdrawal Syndrome, Personal Autonomy, Medication Adherence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-07, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-07 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (qwen3.8-omni-flash).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.